Loading cancer entity…
Loading cancer entity…
Variants & evidence
2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| PDGFRA K3852 | |||||||
| (diagnostic) | Diagnostic | C | Supports Positive | 3 | submitted | EID10669Mutations at codon K385 are specific to glial and glioneuronal tumors. In addition, tumors with these mutations do not typically have other pathogenic mutations in other typical brain-cancer-associate… (full text at CIViC) PMID 30006677 · Solomon et al., 2018 · Open in CIViC | civic |
| 〃 | Diagnostic | C | Supports Positive | 3 | submitted | EID10670PDGFRA K385L (6) or K385I (2) mutations were identified as the sole somatic pathogenic alteration in 8 patients with low-grade glioneuronal tumors; furthering defining "Myxoid glioneuronal tumor, PDGF… (full text at CIViC) PMID 31609499 · Lucas et al., 2020 · Open in CIViC | civic |
Data updated 23 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.